Safety & Health magazine covers an OHSU study led by Emily (Yueng-hsiang) Huang, Ph.D., that identifies ill-fitting protective equipment, discrimination, underrepresentation and inadequate training as key workplace challenges facing women in construction trades. The research team writes, “By engaging top managers, supervisors and workers, the construction industry can advance fairness, mentorship and respectful work environments, ultimately improving the safety, health and well-being of tradeswomen.”

Robert Eil, M.D., speaks with KPTV Fox 12 NOW about his new study that found tumors can evade the immune system by releasing the antioxidant protein PRDX1, which removes molecules T cells need to attack cancer, revealing a potential new immunotherapy target. “One of the surprising findings is that antioxidants aren't always beneficial in the context of cancer,” he says.

Fierce Healthcare examines how hospitals are improving substance use disorder care through multidisciplinary addiction medicine teams and standardized treatment pathways. OHSU’s IMPACT program, founded by Honora Englander, M.D., is featured as a national model that has improved treatment engagement, reduced costs and strengthened addiction care in hospitals and communities. She says in the beginning, “Despite having a really committed staff and well-intended clinicians across disciplines, we really didn't have systems or structures in place to care for people with substance use disorder in the hospital.”

In a Health story on a new study that suggests hormone therapy may be linked to lower dementia risk, Emily Griffin, M.D., who wasn’t involved in the study, says, “They compared people who developed dementia with those who didn’t, then looked for factors that may have influenced those outcomes. That approach uncovers patterns, but it can’t prove cause and effect.”

Medscape writes about weight regain and depression after stopping a GLP-1 medication, with advice for clinicians. Ryan Tweet, Psy.D., says, “Obesity behaves like a chronic condition. When treatment or life circumstances change, regain is common, and change is achievable again. Your prior progress is proof you are not back at zero.”

In a study published in Science, Robert Eil, M.D., along with investigators at the University of Cambridge, discovered that immune cells called T cells need small amounts of reactive oxygen species, or ROS, to effectively attack cancer. Eil says, “One of the surprising findings is that antioxidants aren't always beneficial in the context of cancer.”

OHSU is among the organizations that advocated for the Better Sheridan project, which added protected bicycle infrastructure to improve safety on South Sheridan Street.

In a Medscape story about how gestational diabetes is significantly associated with an increased cardiometabolic risk within the first few years postpartum, Amy Valent, D.O., says, “Although MarketScan data are not without limitations, their size and breadth make it possible to evaluate these important associations in large populations without the expense and complexity of a long-term prospective trial.”

In a study published in Science, Robert Eil, M.D., along with investigators at the University of Cambridge, discovered that immune cells called T cells need small amounts of reactive oxygen species, or ROS, to effectively attack cancer. Eil says, “One of the surprising findings is that antioxidants aren't always beneficial in the context of cancer.”

Medpage Today compiles a list of “quotable quotes” from its reporters, including one from Ahmad Masri, M.D., discussing results from a trial of aficamten (Myqorzo) in symptomatic nonobstructive hypertrophic cardiomyopathy, “Every way, shape, or form you look at this there was benefit.”